GlaxoSmithKline (Germany)
In research, GlaxoSmithKline (Germany) stands highest in Medicine (#7,311 of 17,978 worldwide) and Health Sciences (#9,763 of 20,462 worldwide), over all time.
- World rank, all time
- #12,733 of 42,892
- Rank in Germany
- #624 of 2,077
- Research works
- 382 ▲ 22% vs 2013–17
- Citations
- 15k 38.0 per fractional work
- Top-10% rate
- 16.8% record average 16.5%
- Open access
- 37% world 28%
What is GlaxoSmithKline (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #7,311 of 17,978 | 28.1% | 198 | |
| Health SciencesDomain | #9,763 of 20,462 | 27.3% | 211 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.5×. Every wedge is a field page.
- Immunology and Microbiology 4.5×
- Medicine 3.3×
- Dentistry 2.5×
- Economics, Econometrics and Finance 1.8×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Chemistry 1.6×
- Health Professions 1.3×
- Nursing 1.1×
- Veterinary 1.0×
- Mathematics 0.9×
- Business, Management and Accounting 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Environmental Science 0.4×
- Neuroscience 0.3×
- Social Sciences 0.2×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Psychology 0.1×
- Decision Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at GlaxoSmithKline (Germany)?
Ranked on the composite score, Egon Schwarz, R Welte and Michael Hennig lead among researchers whose main affiliation is GlaxoSmithKline (Germany).
- 1 Egon Schwarz Germany · #183,019 worldwide 30 citations · 32 works
- 2 R Welte Germany · #820,931 worldwide 43 citations · 17 works
- 3 Michael Hennig Germany · #1,096,308 worldwide 35 citations · 15 works
Which keywords describe research at GlaxoSmithKline (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Vaccine, Diagnosis, Inflammation, Management, Asthma and Genetics.
- Immunosuppressive Therapy
- Coronavirus
- Treatment Guidelines
- Neisseria meningitidis
- Cost-effectiveness Analysis
- Mass Spectrometry
- PD-1 and PD-L1
- Tumor Microenvironment
- Clinical Trials
- Chemotherapy
- Clinical Practice Guidelines
- Respiratory
- Immunity
- Global Burden
- Eosinophils
- Immunology
- Asthma
- Diagnosis
- Vaccine
- Treatment
- Epidemiology
- Inflammation
- Quality of Life
- Management
- Genetics
- Allergic Diseases
- Pathogenesis
- Immune Response
- Pandemic
- COPD
- spirometry
- ACE2 Receptor
- SARS-CoV-2
- Immune Checkpoint Blockade
- Vaccine Development
- Bacterial Meningitis
- Health Utility Measures
- Proteomics
- Chronic Cough
- Cough Reflex Sensitivity
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology12▲ 5.7×41 topics
- Treatment5▲ 7.8×16 topics
- Inflammation5▲ 4.5×13 topics
- Vaccine4▲ 20×11 topics
- Quality of Life4▲ 5.4×11 topics
- Diagnosis4▲ 7.8×16 topics
- Management4▲ 9.0×10 topics
- Asthma4▲ 71×2 topics
- Genetics4▲ 9.8×4 topics
- Immunology4▲ 63×2 topics
- Allergic Diseases3▲ 102×1 topic
- Eosinophils3▲ 102×1 topic
- Pathogenesis3▲ 12×12 topics
- Global Burden3▲ 10.0×5 topics
- Immune Response3▲ 9.0×11 topics
- Immunity2▲ 12×4 topics
- Pandemic2▲ 4.1×6 topics
- Respiratory2▲ 43×2 topics
- COPD2▲ 59×1 topic
- Clinical Practice Guidelines2▲ 7.0×9 topics
- spirometry2▲ 59×1 topic
- Chemotherapy2▲ 5.3×8 topics
- ACE2 Receptor2▲ 14×2 topics
- Clinical Trials2▲ 5.0×8 topics
- SARS-CoV-22▲ 10×3 topics
- Tumor Microenvironment2▲ 7.3×3 topics
- Immune Checkpoint Blockade2▲ 25×1 topic
- PD-1 and PD-L12▲ 25×1 topic
- Vaccine Development2▲ 11×8 topics
- Mass Spectrometry1▲ 17×3 topics
- Bacterial Meningitis1▲ 117×1 topic
- Cost-effectiveness Analysis1▲ 29×1 topic
- Health Utility Measures1▲ 29×1 topic
- Neisseria meningitidis1▲ 117×1 topic
- Proteomics1▲ 39×2 topics
- Treatment Guidelines1▲ 11×3 topics
- Chronic Cough1▲ 92×1 topic
- Coronavirus1▲ 11×3 topics
- Cough Reflex Sensitivity1▲ 92×1 topic
- Immunosuppressive Therapy1▲ 12×5 topics
Which research topics does GlaxoSmithKline (Germany) publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer Immunotherapy and Biomarkers and Bacterial Infections and Vaccines.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 3 works
- 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Bacterial Infections and Vaccines Microbiology 1 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 6 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
- 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 9 Herpesvirus Infections and Treatments Epidemiology 1 works
- 10 Vaccine Coverage and Hesitancy Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (Germany)'s research output changed?
Output in 2018–2022 was 22% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hamburg
- Universität Hamburg
- University Medical Center Hamburg-Eppendorf
- Hamburg University of Technology
- Deutsches Elektronen-Synchrotron DESY
- Helmut Schmidt University
- HAW Hamburg
- Institute for Peace Research and Security Policy
- Philips (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.